Checkpoint Therapeutics Inc 's

• CKPT's Stock Performance relative to its Competitors

Zymeworks Inc Share Performance +5.82% This Year

Zymeworks Inc Profile Zymeworks Inc is a biotechnology company that operates on a licensing and collaboration business model. They primarily generate revenue through partnerships and collaborations with pharmaceutical and biotechnology companies, providing access to their proprietary drug development platform and expertise in protein engineering. This enables them to advance the development of novel bi-specific antibodies and therapeutic proteins for the treatment of various diseases and medical conditions. More about Zymeworks Inc 's Market Share

Pliant Therapeutics Inc Share Performance +3.18% Over The Past 5 Days

Pliant Therapeutics Inc Profile Pliant Therapeutics Inc operates with a business model focused on developing novel therapeutics to address fibrotic diseases. The company conducts extensive research to identify and target specific molecular pathways involved in fibrosis, with the aim of developing effective treatments. Pliant Therapeutics collaborates with academic institutions and conducts preclinical and clinical studies to bring its products to market and improve the lives of patients suffering from fibrotic conditions. More about Pliant Therapeutics Inc 's Market Share

Phio Pharmaceuticals Corp Share Performance -0.96% 30 Days

Phio Pharmaceuticals Corp Profile Phio Pharmaceuticals Corp's business model revolves around developing and commercializing innovative RNA-based therapeutics to treat various diseases and improve patient outcomes. More about Phio Pharmaceuticals Corp's Market Share

Panbela Therapeutics Inc Share Performance -99.09% This Quarter

Panbela Therapeutics Inc Profile Panbela Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative and effective treatments for pancreatic cancer. They aim to leverage their expertise in drug development and strategic partnerships to bring novel therapies to the market and address the unmet medical needs of patients with this devastating disease. More about Panbela Therapeutics Inc 's Market Share

Oramed Pharmaceuticals Inc Share Performance +114.72% One Year

Oramed Pharmaceuticals Inc Profile Oramed Pharmaceuticals Inc. is a biopharmaceutical company with a business model focused on developing innovative oral drug delivery solutions. More about Oramed Pharmaceuticals Inc's Market Share

Sources: Checkpoint Therapeutics inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 9:23 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Checkpoint Therapeutics inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.